TYMS, the gene that encodes thymidylate synthase, has been demonstrated to be an independent prognostic biomarker of patients that have undergone 5-fluorouracil chemotherapy for the treatment of gastrointestinal tumors (6). Here, TYMS is linked to digestive system neoplasm.